These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1097 related articles for article (PubMed ID: 29171040)
21. Plantamajoside inhibits the proliferation and epithelial-to-mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia-inducible factor-1α-dependent gene expression. Yin W; Xu J; Li C; Dai X; Wu T; Wen J Cell Biol Int; 2020 Aug; 44(8):1616-1627. PubMed ID: 32239594 [TBL] [Abstract][Full Text] [Related]
22. IL-1β-Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up-regulating Programmed Death Ligand 1 and Colony-Stimulating Factor 1. He Q; Liu M; Huang W; Chen X; Zhang B; Zhang T; Wang Y; Liu D; Xie M; Ji X; Sun M; Tian D; Xia L Hepatology; 2021 Dec; 74(6):3174-3193. PubMed ID: 34288020 [TBL] [Abstract][Full Text] [Related]
23. Hypoxia-induced activation of HIF-1alpha/IL-1beta axis in microglia promotes glioma progression via NF-κB-mediated upregulation of heparanase expression. Si J; Guo J; Zhang X; Li W; Zhang S; Shang S; Zhang Q Biol Direct; 2024 Jun; 19(1):45. PubMed ID: 38863009 [TBL] [Abstract][Full Text] [Related]
24. Knockdown of HIF-1α and IL-8 induced apoptosis of hepatocellular carcinoma triggers apoptosis of vascular endothelial cells. Choi SH; Park JY; Kang W; Kim SU; Kim do Y; Ahn SH; Ro SW; Han KH Apoptosis; 2016 Jan; 21(1):85-95. PubMed ID: 26467924 [TBL] [Abstract][Full Text] [Related]
25. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis. Liu L; Zhu XD; Wang WQ; Shen Y; Qin Y; Ren ZG; Sun HC; Tang ZY Clin Cancer Res; 2010 May; 16(10):2740-50. PubMed ID: 20460486 [TBL] [Abstract][Full Text] [Related]
26. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment. Li Q; Ma L; Shen S; Guo Y; Cao Q; Cai X; Feng J; Yan Y; Hu T; Luo S; Zhou L; Peng B; Yang Z; Hua Y J Exp Clin Cancer Res; 2019 Jul; 38(1):303. PubMed ID: 31296243 [TBL] [Abstract][Full Text] [Related]
27. Increased expression of PHD3 represses the HIF-1 signaling pathway and contributes to poor neovascularization in pancreatic ductal adenocarcinoma. Tanaka T; Li TS; Urata Y; Goto S; Ono Y; Kawakatsu M; Matsushima H; Hirabaru M; Adachi T; Kitasato A; Takatsuki M; Kuroki T; Eguchi S J Gastroenterol; 2015 Sep; 50(9):975-83. PubMed ID: 25542265 [TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition. Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828 [TBL] [Abstract][Full Text] [Related]
29. Basil polysaccharide inhibits hypoxia-induced hepatocellular carcinoma metastasis and progression through suppression of HIF-1α-mediated epithelial-mesenchymal transition. Feng B; Zhu Y; Sun C; Su Z; Tang L; Li C; Zheng G Int J Biol Macromol; 2019 Sep; 137():32-44. PubMed ID: 31252022 [TBL] [Abstract][Full Text] [Related]
30. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α. Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114 [TBL] [Abstract][Full Text] [Related]
31. Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice. Huang W; Chen Z; Zhang L; Tian D; Wang D; Fan D; Wu K; Xia L Gastroenterology; 2015 Oct; 149(4):1053-67.e14. PubMed ID: 26065367 [TBL] [Abstract][Full Text] [Related]
32. Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma. Jiao M; Nan KJ Int J Oncol; 2012 Feb; 40(2):461-8. PubMed ID: 21922131 [TBL] [Abstract][Full Text] [Related]
33. Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma. Zhou X; Chen J; Yi G; Deng M; Liu H; Liang M; Shi B; Fu X; Chen Y; Chen L; He Z; Wang J; Liu J Oncotarget; 2016 Jan; 7(1):873-84. PubMed ID: 26621849 [TBL] [Abstract][Full Text] [Related]
34. Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma. Liu Z; Wang Y; Dou C; Xu M; Sun L; Wang L; Yao B; Li Q; Yang W; Tu K; Liu Q Theranostics; 2018; 8(17):4649-4663. PubMed ID: 30279729 [No Abstract] [Full Text] [Related]
36. HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway. Yang SW; Zhang ZG; Hao YX; Zhao YL; Qian F; Shi Y; Li PA; Liu CY; Yu PW Oncotarget; 2017 Feb; 8(6):9535-9545. PubMed ID: 28076840 [TBL] [Abstract][Full Text] [Related]
37. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway. Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741 [TBL] [Abstract][Full Text] [Related]
38. Silencing of hypoxia-inducible factor-1β induces anti-tumor effects in hepatoma cell lines under tumor hypoxia. Choi SH; Chung AR; Kang W; Park JY; Lee MS; Hwang SW; Kim DY; Kim SU; Ahn SH; Kim S; Han KH PLoS One; 2014; 9(7):e103304. PubMed ID: 25068796 [TBL] [Abstract][Full Text] [Related]
39. Hypoxia-responsive lncRNA MIR155HG promotes PD-L1 expression in hepatocellular carcinoma cells by enhancing HIF-1α mRNA stability. Qiu J; Zhong F; Zhang Z; Pan B; Ye D; Zhang X; Yao Y; Luo Y; Wang X; Tang N Int Immunopharmacol; 2024 Jul; 136():112415. PubMed ID: 38850791 [TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma. Yao DF; Jiang H; Yao M; Li YM; Gu WJ; Shen YC; Qiu LW; Wu W; Wu XH; Sai WL Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):407-13. PubMed ID: 19666411 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]